Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: The Eurgast-EPIC project

Annals of Oncology

Volumn 23, Issue 5, 2012, Pages 1320-1324

  Gonzalez C A ^a   Megraud, F ^b   Buissonniere, A ^b   Lujan Barroso, L ^a   Agudo, A ^a   Duell, E J ^a   Boutron Ruault, M C ^c,d   Clavel Chapelon, F ^c,d   Palli, D ^e   Krogh, V ^f   Mattiello, A ^g   Tumino, R ^h   Sacerdote, C ⁱ   Quiros J R ^j   Sanchez Cantalejo, E ^k   Navarro, C ^l   Barricarte, A ^m   Dorronsoro, M ⁿ   Khaw, K T ^o   Wareham, N ^o   Allen, N E ^p   Tsilidis, K K ^p   Bas Bueno de Mesquita, H ^q,r   Jeurnink, S M ^q,r   Numans, M E ^r   Peeters, P H M ^r   Lagiou, P ^s   Valanou, E ^t   Trichopoulou, A ^t   Kaaks, R ^u   Lukanova McGregor, A ^u   Bergman, M M ^v   Boeing, H ^w   Manjer, J ^x   Lindkvist, B ^y   Stenling, R ^y   Hallmans, G ^z   Mortensen, L M ^z   Overvad, K ^aa   Olsen, A ^aa   Tjonneland, A ^ab   Bakken, K ^ab   Dumeaux, V ^ab   Lund, E ^ac   Jenab, M ^ac   Romieu, I ^ac   Michaud, D ^ad   Mouw, T ^ad   Carneiro, F ^ae   Fenge, C ^af   Riboli, E ^ad   more..

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b INSERM U853 ^*  (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^f NATIONAL CANCER INSTITUTE   (Italy)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^h CIVILE M P AREZZO HOSPITAL   (Italy)

ⁱ Reference Centre for Cancer Epidemiology and Prevention   (Italy)

^j Health and Health Care Services Council   (Spain)

^k ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^l DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^m INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

ⁿ Basque Government   (Spain)

^o UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^p UNIVERSITY OF OXFORD   (United Kingdom)

^q NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^r UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^s UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^t HELLENIC HEALTH FOUNDATION   (Greece)

^u GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^v GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^w LUND UNIVERSITY HOSPITAL   (Sweden)

^x SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^y UMEÅ UNIVERSITY   (Sweden)

^z AARHUS UNIVERSITY   (Denmark)

^aa INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^ab UNIVERSITY OF TROMSØ   (Norway)

^ac INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^ad IMPERIAL COLLEGE LONDON   (United Kingdom)

^ae University of Porto   (Portugal)

^af ODENSE UNIVERSITY HOSPITAL   (Denmark)

more..

Author keywords

Helicobacter pylori; Noncardia gastric cancer; Prospective study; Western blot

Indexed keywords

CAGA PROTEIN; IMMUNOGLOBULIN G ANTIBODY; PEPSINOGEN I;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CAUSAL ATTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HELICOBACTER INFECTION; HUMAN; IMMUNOBLOTTING; INFECTION RISK; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONCARDIA GASTRIC CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SEROPREVALENCE; STOMACH CANCER;

EID: 84859403982     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr384     Document Type: Article

References (20)

1. Correa P, Houghton JM. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007; 133: 659-672.
2. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49: 347-353.
3. Huang JQ, Zheng GF, Sumanac K et al. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 2003; 125(6): 1636-1644.
4. Ekström AM, Held M, Hansson LE et al. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001; 121(4): 784-791.
5. Sö rberg M, Engstrand L, Ström M et al. The diagnostic value of enzyme immunoassay and immunoblot in monitoring eradication of Helicobacter pylori. Scand J Infect Dis 1997; 29(2): 147-151.
6. Mini R, Annibale B, Lahner E et al. Western blotting of total lysate of Helicobacter pylori in cases of atrophic body gastritis. Clin Chem 2006; 52(2): 220-226.
7. Enroth H, Kraaz W, Rohan T et al. Does the method of Helicobacter pylori detection influence the association with gastric cancer risk? Scand J Gastroenterol 2002; 37(8): 884-890.
8. Mitchell H, English DR, Elliott F et al. Immunoblotting using multiple antigens is essential to demonstrate the true risk of Helicobacter pylori infection for gastric cancer. Aliment Pharmacol Ther 2008; 28(7): 903-910.
9. Brenner H, Arndt V, Stegmaier C et al. Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? Am J Epidemiol 2004; 159(3): 252-258.
10. Palli D, Masala G, Del Giudice G et al. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int J Cancer 2007; 120(4): 859-867.
11. Riboli E, Hunt KJ, Slimani N et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002; 5(6B): 1113-1124.
12. Carneiro F, Moutinho C, Pera G et al. Pathology findings and validation of gastric and esophageal cancer cases in a European cohort (EPIC/EUR-GAST). Scand J Gastroenterol 2007; 42(5): 618-627.
13. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118(12): 3030-3044.
14. Buehler JW. Surveillance. In Rothman KJ, Greenland S (eds), Modern Epidemiology, 2nd edition. Philadelphia, PA: Lippincott Williams and Wilkins 1998.
15. Kekki M, Samloff IM, Varis K, Ihamä ki T. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol Suppl. 1991; 186: 109-116.
16. Ye W, Held M, Enroth H et al. Histology and culture results among subjects with antibodies to CagA but no evidence of Helicobacter pylori infection with IgG ELISA. Scand J Gastroenterol 2005; 40(3): 312-318.
17. Monteriro L, Bergey B, Gras N, Mégraud F. Evaluation of the performance of the Helico Blot 2.1 as a tool to investigate the virulence properties of Helicobacter pylori. Clin Microbiol Infect 2002; 8(10): 679-69l.
18. Simán JH, Engstrand L, Berglund G et al. Evaluation of western blot CagA seropositivity in Helicobacter pylori-seropositive and -seronegative subjects. Clin Diagn Lab Immunol 2005; 12(2): 304-309.
19. Yeh JM, Goldie SJ, Kuntz KM, Ezzati M. Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections. Cancer Causes Control 2009; 20(10): 2021-2029.
20. Herrera V, Parsonnet J. Helicobacter pylori and gastric adenocarcinoma. Clin Microbiol Infect 2009; 15(11): 971-976.